SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-075690
Filing Date
2019-12-23
Accepted
2019-12-23 17:22:31
Documents
8
Period of Report
2019-12-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv535092_8k.htm 8-K 26087
2 EXHIBIT 1.1 tv535092_ex1-1.htm EX-1.1 300007
3 EXHIBIT 4.1 tv535092_ex4-1.htm EX-4.1 72518
4 EXHIBIT 5.1 tv535092_ex5-1.htm EX-5.1 9542
5 EXHIBIT 10.1 tv535092_ex10-1.htm EX-10.1 28121
6 EXHIBIT 99.1 tv535092_ex99-1.htm EX-99.1 11491
7 GRAPHIC tv535092_ex99-1img01.jpg GRAPHIC 4188
8 GRAPHIC image_002.jpg GRAPHIC 5166
  Complete submission text file 0001104659-19-075690.txt   462524
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 191307225
SIC: 2834 Pharmaceutical Preparations